CYTORI THERAPEUTICS, INC. 4
4 · CYTORI THERAPEUTICS, INC. · Filed Jan 4, 2016
Insider Transaction Report
Form 4
HARRIS JOHN DAVID
VP and GM Cell Therapy
Transactions
- Award
Employee Stock Option
2016-01-04+349,830→ 684,830 totalExp: 2026-01-04→ Common Stock (349,830 underlying)
Footnotes (2)
- [F1]The reporting person received an NQ stock option granted under the Corporation's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing sale price of the Corporation's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price is $0.1872.
- [F2]Twenty five percent (25%) of the option shares shall vest on January 4, 2017 with the remaining option shares vesting in 36 equal monthly installments thereafter.